Expression of NAC1 Restrains the Memory Formation of CD8 + T Cells during Viral Infection.
Liqing WangAnil KumarJugal Kishore DasYijie RenHao-Yun PengDarby Jane BallardXiaofang XiongJacob Rance DavisXingcong RenJin-Ming YangJianxun SongPublished in: Viruses (2022)
Nucleus accumbens-associated protein 1 (NAC1) is a transcription co-factor that has been shown to possess multiple roles in stem cell and cancer biology. However, little is known about its roles in regulation of the immune system. In the current study, we observed that expression of NAC1 impacted the survival of CD8 + T cells in vitro. NAC1 -/- CD8 + T cells displayed lower metabolism, including reduced glycolysis and oxidative phosphorylation. In vivo, compared with wild-type (WT) mice, NAC1 -/- mice produced a lower response to vaccinia virus (VACV) infection, and viral antigen (Ag)-specific CD8 + T cells decreased more slowly. Additionally, we observed that the NAC1 -/- mice demonstrated a stronger memory formation of viral Ag-specific CD8 + T cells post-viral infection. Mechanically, we identified that compared with WT CD8 + T cells, the Interferon Regulatory Factor 4 (IRF4), a key transcription factor in T cell development, was highly expressed in NAC1 -/- CD8 + T cells, insinuating that IRF4 could be a critical regulatory target of NAC1 in the memory formation of CD8 + T cells. Our results indicate that NAC1 restrains the memory formation of CD8 + T cells by modulating IRF4, and targeting NAC1 may be exploited as a new approach to boosting CD8 + T cell memory.
Keyphrases
- transcription factor
- dna binding
- wild type
- working memory
- stem cells
- dendritic cells
- genome wide identification
- poor prognosis
- sars cov
- genome wide analysis
- high fat diet induced
- quantum dots
- drug delivery
- signaling pathway
- metabolic syndrome
- squamous cell carcinoma
- skeletal muscle
- binding protein
- cell therapy
- childhood cancer